Mr. Jones is to receive 2.25 mL of a liquid medication every 4 hours. How much medication will he receive during
days?
A. 50 mL
B. 40.5 mL
C. 47.25 mL
D. 13.5 mL
Answer: C
You might also like to view...
How does modern medical care differ from CULTURALCARE in the medicalization of life?
A. Application of the medical model and technologies to problems not thought of as medical in nature B. Application of knowledge to the entire sociocultural and health context of patients C. Acknowledging that treatment may not yield a better quality of life D. Application of patient traditions in health treatments.
A 79-year-old female patient, admitted for hip replacement surgery, complained of insomnia the night before and was administered lorazepam, a benzodiazepine
She began displaying signs of delirium shortly thereafter, a situation that has persisted until the morning change of shift. Which of the following guidelines should the night nurse provide to the nurse coming on shift to care for the patient? A) "Make sure you get a sedative order from her doctor this morning.". B) "Try to keep her level of stimulation as low as you can when you are working with her.". C) "Make sure you let the family know that there are effective drug treatments that will resolve her delirium.". D) "Work with the discharge-planning nurse to help the family reassess her living arrangement after discharge.".
Successful implementation of a system can be facilitated by addressing significant barriers presented by staff. Which aspect of resistance should be addressed by committee members during the planning phase?
1. Staff members need to control the workflow and do not want changes imposed on them. 2. The impact of the change on off shift personnel 3. The nurse to patient ratio 4. Emotions of staff
A nurse working in a private pediatric practice is caring for a patient who has been receiving 17–alpha-alkylated androgen (Fluoxymesterone)
Which clinical manifestation would cause the nurse to be concerned, and what intervention would the nurse anticipate? a. Gynecomastia; discontinuation of the drug b. Yellowish tint to the skin and sclera; discontinuation of the drug c. Decrease in high-density lipoprotein (HDL); titration of the medication d. Erratic blood glucose levels; adjustment of the dose